Human Anti-TNFRSF25 Recombinant Antibody (clone Ch142A2) (CAT#: HPAB-0333-YJ)

This product is a recombinant Chimeric (Human/Mouse) antibody that recognizes human TNFRSF25. It displays a decreased agonistic activity or no agonistic activity for DR3.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FuncS

Figure 1 indicate comparison of isotype effects on anti-DR3 antibody agonist activities.

Figure 1 indicate comparison of isotype effects on anti-DR3 antibody agonist activities.

The effects of indicated 142A2 IgG1, IgG2, and IgG4v versions on PBMCs NF-kB activation were determined. The longitudinal axis indicates p65 phosphorylation-positive cells (%) in PBMCs and the horizontal axis indicates added antibodies. TL1A was added at 40 nM concentration and each antibody was added at 6.67 nM concentration.

FuncS

Figure 2 indicate comparison of isotype effects on anti-DR3 antibody antagonist activities.

Figure 2 indicate comparison of isotype effects on anti-DR3 antibody antagonist activities.

The effects of indicated 142A2 IgG1, IgG2, and IgG4v versions on PBMCs NF-kB activation were determined. The longitudinal axis indicates p65 phosphorylation-positive cells (%) in PBMCs and the horizontal axis indicates added antibodies. TL1A was added at 40 nM concentration and each antibody was added at 6.67 nM concentration.

FuncS

Figure 3 indicate an agonism on p65 phosphorylation level of anti-DR3 antibody IgG2, IgG4 variant, IgG4244 variant and IgG2422 variant.

Figure 3 indicate an agonism on p65 phosphorylation level of anti-DR3 antibody IgG2, IgG4 variant, IgG4244 variant and IgG2422 variant.

The longitudinal axis indicates p65 phosphorylation-positive cells (%) in PBMCs and the horizontal axis indicates antibody concentration (nM).

FuncS

Figure 4 indicate an antagonism on p65 phosphorylation level of anti-DR3 antibody IgG2, IgG4 variant, IgG4244 variant and IgG2422 variant.

Figure 4 indicate an antagonism on p65 phosphorylation level of anti-DR3 antibody IgG2, IgG4 variant, IgG4244 variant and IgG2422 variant.

The longitudinal axis indicates p65 phosphorylation-positive cells (%) in PBMCs and the horizontal axis indicates antibody concentration (μgmL). 55% and 1.8% of cells were phosphorylated-p65 positive following TL1A treatment alone or medium alone.


Specifications

  • Host Species
  • Human
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • Chimeric (mouse/human) IgG2, κ
  • Specificity
  • Human TNFRSF25
  • Species Reactivity
  • Human
  • Clone
  • Ch142A2
  • Applications
  • FC, Antagonism, FuncS

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been reported for use in Flow Cytometry, Antagonism, Functional Assay.

Target

  • Alternative Names
  • DR3; TR3; DDR3; LARD; APO-3; TRAMP; WSL-1; GEF720; WSL-LR; PLEKHG5; TNFRSF12; death receptor 3; tumor necrosis factor receptor superfamily member 25; Guanine nucleotide exchange factor 720; PH domain-containing family G member 5; Pleckstrin homology domain-containing family G member 5; apoptosis inducing receptor; apoptosis-inducing receptor AIR; apoptosis-mediating receptor DR3; apoptosis-mediating receptor TRAMP; death domain receptor 3 soluble form; death receptor beta; lymphocyte-associated receptor of death; protein WSL-1; tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein)

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone Ch142A2"

See other products for "TNFRSF25"

Humanized Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-0333-YJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare